1. ALLA AKTIER
  2. NYHETER
  3. AROCELL

AroCell

Nyheter AroCell Nyheter alla bolag

TPS CLIA has received approval for use on Fosun Diagnostics' fully automated system in China

Our partner, ZECEN Biotech, has received the registration certificate from the Chinese registration authorities NMPA. This means that TPS CLIA is now also approved for use on Fosun Diagnostics' fully automated CLIA platforms in China.

“We are happy that this product is approved and ready to be launched on the Chinese market. The expansion of TPS on different platforms will result in a broader reach and increased presence on the market. We are looking forward to continuing our collaboration with ZECEN Biotech, and expanding collaboration into other tumor markers on their machines in the future” says Marie Torstensson, Chief Market and Sales Officer Laboratory Test.
 
About ZECEN Biotech
ZECEN Biotech Co., Ltd., is a Chinese company that mainly specializes in providing total chemiluminescence immunoassay solutions by developing, manufacturing, and marketing CLIA instruments and reagents. The company has research and development centers and a production base in Beijing, Shandong, and Jiangsu. ZECEN Biotech Co., Ltd., and cooperates with leading hospitals in China.

About Fosun Diagnostics
Fosun Diagnostics is a division within Shanghai Fosun Pharmaceutical (Group) Co Ltd, focusing on developing, manufacturing, and distributing in vitro diagnostics (IVD) products.

Contacts

Anders Hultman, CEO
Phone: +46 (0) 8 799 67 50
E-mail: anders.hultman@arocell.com

About AroCell

AroCell AB (publ) is a Swedish company that develops and markets blood and urine sample tests. The corporation specializes in oncology and bacteriology. The company has a broad product portfolio, used in healthcare, and established in various markets. In oncology, AroCell uses various biomarkers, TK1, and cytokeratins, to support the treatment of various cancers such as breast, prostate, and bladder cancers. AroCell's product portfolio also includes a rapid bacteriological test for a simple and safe diagnosis of typhoid fever. AroCell (AROC) is listed on Nasdaq First North Growth Market with Redeye AB as company's Certified Adviser. For more information; www.arocell.com

Attachments

TPS CLIA has received approval for use on Fosun Diagnostics' fully automated system in China

Datum 2023-05-31, kl 11:35
Källa MFN
Bifogade filer
TPS CLIA has received approval for use on Fosun Diagnostics' fully automated system in China
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!